Company Performance Metrics
- Jordan Copner: Founder and CEO
Copner Biotech Ltd specializes in the development of 3D cell culture technologies, focusing on the creation of 3D PETG scaffolds for bioprinting applications. Established in 2020, this biotechnology company engages in research and development to advance the field of therapeutics. Their innovative approach includes the use of GRAPE M1 Modelling
Software, which aids in the design and visualization of 3D biological constructs. Copner Biotech is recognized for its contributions to the biotech industry, receiving global awards for its pioneering work. The company collaborates with academic and 'wet lab' facilities to ensure the efficacy and safety of its products, addressing challenges such as sterilization and cellular toxicity.